annual CAPEX:
N/ASummary
- AVDL annual capital expenditures is not available.
Performance
AVDL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- AVDL quarterly capital expenditures is not available.
Performance
AVDL quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- AVDL TTM capital expenditures is not available.
Performance
AVDL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
AVDL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVDL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
AVDL CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $716.00K(+2653.8%) | $0.00(-100.0%) | $716.00K(0.0%) |
| Sep 2022 | - | $716.00K(>+9900.0%) | $716.00K(+2653.8%) |
| Dec 2021 | $26.00K(-73.5%) | $0.00(0.0%) | $26.00K(-71.4%) |
| Sep 2021 | - | $0.00(0.0%) | $91.00K(-26.6%) |
| Jun 2021 | - | $0.00(-100.0%) | $124.00K(0.0%) |
| Mar 2021 | - | $26.00K(-60.0%) | $124.00K(+26.5%) |
| Dec 2020 | $98.00K(+237.9%) | $65.00K(+97.0%) | $98.00K(+197.0%) |
| Sep 2020 | - | $33.00K(>+9900.0%) | $33.00K(+13.8%) |
| Dec 2019 | $29.00K(-99.9%) | $0.00(0.0%) | $29.00K(-27.5%) |
| Sep 2019 | - | $0.00(-100.0%) | $40.00K(-63.0%) |
| Jun 2019 | - | -$1000.00(-103.3%) | $108.00K(-99.5%) |
| Mar 2019 | - | $30.00K(+172.7%) | $20.17M(-0.1%) |
| Dec 2018 | $20.18M(-62.4%) | $11.00K(-83.8%) | $20.18M(-4.8%) |
| Sep 2018 | - | $68.00K(-99.7%) | $21.20M(-71.2%) |
| Jun 2018 | - | $20.06M(>+9900.0%) | $73.48M(+37.6%) |
| Mar 2018 | - | $41.00K(-96.0%) | $53.41M(-0.5%) |
| Dec 2017 | $53.70M(+4371.4%) | $1.03M(-98.0%) | $53.70M(+1.6%) |
| Sep 2017 | - | $52.35M(<-9900.0%) | $52.87M(+6838.7%) |
| Jun 2017 | - | -$13.00K(-103.9%) | $762.00K(-29.1%) |
| Mar 2017 | - | $334.00K(+66.2%) | $1.07M(-10.5%) |
| Dec 2016 | $1.20M(-26.3%) | $201.00K(-16.3%) | $1.20M(-22.6%) |
| Sep 2016 | - | $240.00K(-20.0%) | $1.55M(-10.3%) |
| Jun 2016 | - | $300.00K(-34.8%) | $1.73M(-6.7%) |
| Mar 2016 | - | $460.00K(-16.7%) | $1.85M(+13.9%) |
| Dec 2015 | $1.63M(-5.7%) | $552.00K(+32.1%) | $1.63M(+16.3%) |
| Sep 2015 | - | $418.00K(-1.6%) | $1.40M(-16.4%) |
| Jun 2015 | - | $425.00K(+81.6%) | $1.68M(+7.2%) |
| Mar 2015 | - | $234.00K(-27.8%) | $1.56M(-9.5%) |
| Dec 2014 | $1.73M(+67.9%) | $324.00K(-53.2%) | $1.73M(+3.7%) |
| Sep 2014 | - | $692.00K(+121.1%) | $1.67M(+36.0%) |
| Jun 2014 | - | $313.00K(-21.6%) | $1.23M(+21.9%) |
| Mar 2014 | - | $399.00K(+51.7%) | $1.01M(-2.2%) |
| Dec 2013 | $1.03M(-3.7%) | $263.00K(+4.8%) | $1.03M(-0.1%) |
| Sep 2013 | - | $251.00K(+169.9%) | $1.03M(-3.7%) |
| Jun 2013 | - | $93.00K(-78.0%) | $1.07M(-7.4%) |
| Mar 2013 | - | $422.00K(+59.8%) | $1.16M(+8.0%) |
| Dec 2012 | $1.07M(-43.8%) | $264.00K(-9.3%) | $1.07M(-4.9%) |
| Sep 2012 | - | $291.00K(+63.5%) | $1.12M(-1.0%) |
| Jun 2012 | - | $178.00K(-47.0%) | $1.14M(-15.2%) |
| Mar 2012 | - | $336.00K(+5.3%) | $1.34M(-29.7%) |
| Dec 2011 | $1.90M | $319.00K(+5.6%) | $1.90M(-1.4%) |
| Sep 2011 | - | $302.00K(-20.7%) | $1.93M(-30.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $381.00K(-57.7%) | $2.77M(-26.4%) |
| Mar 2011 | - | $901.00K(+160.4%) | $3.76M(+4.6%) |
| Dec 2010 | $3.60M(+103.3%) | $346.00K(-69.7%) | $3.60M(+3.1%) |
| Sep 2010 | - | $1.14M(-16.8%) | $3.49M(+20.2%) |
| Jun 2010 | - | $1.37M(+86.7%) | $2.90M(+38.7%) |
| Mar 2010 | - | $736.00K(+209.2%) | $2.10M(+18.4%) |
| Dec 2009 | $1.77M(-49.8%) | $238.00K(-57.3%) | $1.77M(+9.3%) |
| Sep 2009 | - | $557.00K(-1.2%) | $1.62M(-43.7%) |
| Jun 2009 | - | $564.00K(+37.2%) | $2.88M(+4.7%) |
| Mar 2009 | - | $411.00K(+372.4%) | $2.75M(-22.1%) |
| Dec 2008 | $3.52M(-68.7%) | $87.00K(-95.2%) | $3.52M(+0.4%) |
| Sep 2008 | - | $1.81M(+316.8%) | $3.51M(-47.7%) |
| Jun 2008 | - | $435.00K(-63.4%) | $6.71M(-27.6%) |
| Mar 2008 | - | $1.19M(+1505.4%) | $9.26M(-17.8%) |
| Dec 2007 | $11.27M(+76.3%) | $74.00K(-98.5%) | $11.27M(-27.0%) |
| Sep 2007 | - | $5.01M(+67.7%) | $15.45M(+44.2%) |
| Jun 2007 | - | $2.99M(-6.6%) | $10.71M(+20.2%) |
| Mar 2007 | - | $3.20M(-24.8%) | $8.92M(+39.4%) |
| Dec 2006 | $6.39M(-43.5%) | $4.25M(+1446.5%) | $6.39M(+10.9%) |
| Sep 2006 | - | $275.00K(-76.9%) | $5.77M(-21.6%) |
| Jun 2006 | - | $1.19M(+76.0%) | $7.36M(-35.6%) |
| Mar 2006 | - | $676.00K(-81.4%) | $11.43M(+0.9%) |
| Dec 2005 | $11.33M(-18.1%) | $3.63M(+94.5%) | $11.33M(+27.1%) |
| Sep 2005 | - | $1.86M(-64.6%) | $8.91M(-25.8%) |
| Jun 2005 | - | $5.26M(+823.5%) | $12.02M(+15.9%) |
| Mar 2005 | - | $570.00K(-53.0%) | $10.37M(-25.0%) |
| Dec 2004 | $13.84M(+387.0%) | $1.21M(-75.6%) | $13.84M(-8.3%) |
| Sep 2004 | - | $4.97M(+37.4%) | $15.10M(+49.1%) |
| Jun 2004 | - | $3.62M(-10.4%) | $10.13M(+54.4%) |
| Mar 2004 | - | $4.04M(+63.2%) | $6.56M(+130.8%) |
| Dec 2003 | $2.84M(+98.0%) | $2.47M(>+9900.0%) | $2.84M(+672.0%) |
| Sep 2003 | - | $0.00(-100.0%) | $368.00K(0.0%) |
| Jun 2003 | - | $49.00K(-84.6%) | $368.00K(+15.4%) |
| Mar 2003 | - | $319.00K(-36.2%) | $319.00K(-36.2%) |
| Dec 2002 | $1.44M(+21.8%) | - | - |
| Dec 2001 | $1.18M(+59.8%) | - | - |
| Dec 2000 | $737.00K(+9.5%) | - | - |
| Dec 1999 | $673.00K(-40.5%) | - | - |
| Dec 1998 | $1.13M(-29.3%) | - | - |
| Mar 1998 | - | $500.00K(+150.0%) | $500.00K(+150.0%) |
| Dec 1997 | $1.60M(+6.7%) | - | - |
| Dec 1996 | $1.50M | - | - |
| Mar 1996 | - | $200.00K | $200.00K |
FAQ
- What is the all time high annual CAPEX for Avadel Pharmaceuticals?
- What is the all time high quarterly CAPEX for Avadel Pharmaceuticals?
- What is the all time high TTM CAPEX for Avadel Pharmaceuticals?
What is the all time high annual CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual capital expenditures is $53.70M
What is the all time high quarterly CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly capital expenditures is $52.35M
What is the all time high TTM CAPEX for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM capital expenditures is $73.48M